Skip to main content

Hepatitis D Virus (HDV) Antibody, IgG and IgM

CPT

86692

Synonyms
  • HBV
  • Hepatitis delta

Test Details

Methodology

Chemiluminescent immunoassay (CLIA)

Result Turnaround Time

Daily

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

Use

This assay is used for the qualitative detection of Hepatitis D virus (HDV) antibodies (IgG/IgM) and is intended to aid in the diagnosis of HDV infection in individuals with known HBV infection (HBsAg-positive). Testing for HDV RNA should be performed on HDV antibody-positive individuals to differentiate between active and resolved HDV infection.

Special Instructions

This assay currently is not available in New York state.

Limitations

A reactive specimen should be investigated further with sensitive, supplemental HDV-specific tests, such as identification of HDV RNA, to be matched with the clinical story of the subject and with markers of a previous HBV infection (HBsAg, anti-HB Core, HBV DNA, etc.). Like all immunoassays, this assay may occasionally yield nonspecific reactions due to other causes. A nonreactive test result for HDV antibodies does not exclude the possibility of exposure to or infection with HDV. Further investigations with alternative HDV-specific tests are suggested in case of suspected infection despite the negative finding.

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

References

European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis delta virus. J Hepatol. 2023 Aug;79(2):433-460. Epub 2023 Jun 24.37364791
Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018 Apr; 67(4):1560-1599.2940532

Specimen Requirements

Specimen

Serum or EDTA-plasma

Volume

0.5 mL

Minimum Volume

0.2 mL (Note: This volume does not allow for repeat testing.)

Container

Gel-barrier tube or lavender-top (EDTA) tube

Collection Instructions

Standard blood collection technique

Stability Requirements

TemperaturePeriod
Room temperature14 days
Refrigerated14 days
Frozen14 days
Freeze/thaw cyclesStable x3

Storage Instructions

Room temperature

Causes for Rejection

Gross hemolysis, lipemia or visible microbial contamination; heat-inactivated samples; specimens other than serum and EDTA plasma

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
144012 HDV Antibody, IgG/IgM 40727-0 144013 HDV Antibody, IgG/IgM 40727-0
Order Code144012
Order Code NameHDV Antibody, IgG/IgM
Order Loinc40727-0
Result Code144013
Result Code NameHDV Antibody, IgG/IgM
UofM
Result LOINC40727-0
Reflex Table for HDV Antibody, IgG/IgM
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 144015 Interpretation: 144015 Interpretation: N/A
Reflex 1
Order Code144015
Order NameInterpretation:
Result Code144015
Result NameInterpretation:
UofM
Result LOINCN/A
Reflex Table for HDV Antibody, IgG/IgM
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 144016 Interpretation: 144016 Interpretation: N/A
Reflex 1
Order Code144016
Order NameInterpretation:
Result Code144016
Result NameInterpretation:
UofM
Result LOINCN/A